Viewing Study NCT03801668


Ignite Creation Date: 2025-12-24 @ 6:25 PM
Ignite Modification Date: 2025-12-30 @ 6:49 PM
Study NCT ID: NCT03801668
Status: UNKNOWN
Last Update Posted: 2022-01-04
First Post: 2019-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Sponsor: Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module